PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,328,666 | +57.2% | 108,509 | +105.4% | 0.01% | +66.7% |
Q2 2023 | $2,116,845 | -33.3% | 52,830 | -32.0% | 0.00% | -25.0% |
Q1 2023 | $3,171,350 | +5.9% | 77,710 | +0.2% | 0.00% | 0.0% |
Q4 2022 | $2,994,360 | -44.0% | 77,554 | -22.9% | 0.00% | -50.0% |
Q3 2022 | $5,350,000 | +107.1% | 100,589 | +127.0% | 0.01% | +100.0% |
Q2 2022 | $2,583,000 | -23.0% | 44,307 | +0.8% | 0.00% | 0.0% |
Q1 2022 | $3,354,000 | +380.5% | 43,945 | +279.0% | 0.00% | +300.0% |
Q4 2021 | $698,000 | – | 11,594 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |